Instructions for Ortanol (omeprazole)
English Product Name
Ortanol®
Release Form
caps. 10 mg: 7, 14 or 28 pcs.
Description Ortanol
The capsules are solid gelatin, size No. 3, with a body and lid of light pink-brown color, on both parts of the capsule the inscription "OME10" is black; the contents of the capsules are granules of light yellow.
1 caps.
omeprazole 10 mg
Auxiliary substances: low-substituted hyprolose - 10 mg, microcrystalline cellulose - 7 mg, anhydrous lactose - 58.5 mg, sodium croscarmellose - 10 mg, povidone - 4 mg, polysorbate 80 - 0.5 mg, phthalate hypromellose - 24.306 mg, dibutylsebakat - 0.447 mg, talc - 0.247 mg.
The composition of the capsule shell: hypromellose - 43.7539 mg, carrageenan - 0.1728 mg, potassium chloride - 0.228 mg, titanium dioxide - 1.3 mg, iron (III) yellow oxide - 0.0518 mg, iron (III) red oxide - 0.0335 mg, water - 2.4 mg.
Ink for inscription: iron (III) black oxide (E172) - 0.064 mg, shellac - 24-27%, anhydrous ethanol - 23-26%, anhydrous isopropanol - 1-3%, propylene glycol - 3-7%, butanol - 1-3%, ammonium hydroxide - 1-2%, potassium hydroxide - 0.05-0.1%, purified water - 15-18%.
7 pcs. - blisters (2) - cardboard packs.
7 pcs. - blisters (4) - cardboard packs.
ATX codes
A02BC01 Omeprazole
Clinical and pharmacological groups / Group affiliation
An H<SUP>+</SUP>-K<SUP>+</SUP>-ATP-ase inhibitor. Antiulcer drug
Active ingredient
- omeprazole
Pharmacological properties Ortanol
Omeprazole acts as an H+-K+-ATP-ase inhibitor, reducing this enzyme's activity in parietal gastric cells. This inhibits the final step of hydrochloric acid secretion, which leads to a reduction in both basal and stimulated secretion, regardless of the irritant type. Decreased acid secretion leads to decreased or normalized esophageal exposure in patients with reflux esophagitis.
Omeprazole is also bactericidal on Helicobacter pylori. Combined use of omeprazole and antibiotics contributes to rapid elimination of H. pylori, allowing rapid symptom reduction, marked healing of mucosal injury, and prolonged remission, reducing the risk of gastrointestinal bleeding.
Testimony omeprazole
The drug is used for exacerbation of peptic ulcer disease of the stomach and duodenum (including cases associated with Helicobacter pylori), reflux esophagitis, Zollinger-Ellison syndrome, and for erosive-ulcerative lesions caused by NSAIDs.
Method of application, dosage Ortanol
Dosage is selected individually. The recommended single dose is 20 to 40 mg, daily 20 to 80 mg; use 1 to 2 times a day for 2 to 8 weeks.
- Nosology omeprazole (ICD codes)
- B98.0
- Helicobacter pylori as a cause of diseases classified elsewhere
- E16.4
- Disorders of gastrin secretion (hypergastrinemia, Zollinger-Ellison syndrome)
- K21.0
- Gastresophageal reflux with esophagitis
- K25
- Gastric ulcer
- K26
- Duodenal ulcer
- Y45
- Analgesic, antipyretic, and anti-inflammatory drugs
